英国主动脉瓣置换联合冠状动脉旁路移植术的趋势与结局及实践调查
103名外科医生的国际调查显示对移植物数量影响结局及分期或杂交干预的看法存在分歧。
要点
- 联合手术中移植血管数量≥2支与死亡率增加相关,单支动脉桥与死亡率和术后透析减少相关。
- 103名外科医生调查中,仅略多数认为移植血管数量可影响短期或长期结局,对分期或杂交干预支持几乎均分。
- 未来需研究不完全血运重建的效果及长期结局,并探讨杂交干预的短期和长期疗效与安全性。
核心结论
- 联合主动脉瓣置换和冠状动脉旁路移植术中移植血管数量与发病率和死亡率增加相关,使用动脉移植物与死亡率降低相关。
- 未来需研究评估不完全血运重建的效果并测量长期结局。
- 基于数据、现有证据和专家意见,作者支持未来研究杂交干预对晚期冠状动脉和主动脉瓣疾病患者的短期和长期疗效与安全性。
研究设计与样本
- 回顾性分析1996年2月至2019年3月英国国家成人心脏手术审计数据中所有接受主动脉瓣置换联合冠状动脉旁路移植术的患者。
- 使用广义混合效应模型评估移植血管数量和类型对院内死亡率、术后卒中和需要肾透析的影响。
- 开展国际横断面调查,收集心脏外科医生对联合主动脉瓣置换联合冠状动脉旁路移植术干预的看法。
主要发现
- 接受2支和>2支移植血管联合主动脉瓣置换的患者较接受主动脉瓣置换和仅1支移植血管的患者死亡率增加(OR 1.17,95%CI 1.05-1.30,P=0.005 和 OR 1.15,95%CI 1.02-1.30,P=0.024)。
- 单支动脉 conduit 与死亡率降低相关(OR 0.75,95%CI 0.68-0.82,P<0.001)和术后透析减少相关(OR 0.87,95%CI 0.78-0.96,P=0.006),但>1支动脉 conduit 时该关联消失。
- 103名外科医生回复调查,仅略多数认为移植血管数量可影响这些患者的短期或长期术后结局,支持分期或杂交干预的回复者几乎均分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来需研究评估不完全血运重建的效果并测量长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Concomitant revascularization of coronary artery disease at the same time as treatment for aortic valvopathy favourably impacts survival. However, combined surgery may be associated with increased adverse outcomes compared to aortic valve replacement (AVR) or coronary artery bypass grafting in isolation. METHODS: We retrospectively analyzed all patients who underwent AVR with bypass grafting between February 1996 and March 2019 using data from the National Adult Cardiac Surgery Audit. We used a generalized mixed-effects model to assess the effect of the number and type of bypass grafts associated with surgical AVR on in-hospital mortality, postoperative stroke, and the need for renal dialysis. Furthermore, we conducted an international cross-sectional survey of cardiac surgeons to explore their views about concomitant AVR with coronary bypass grafting interventions. RESULTS: Fifty-one thousand two hundred and seventy-two patients were included in the study. Patients receiving 2 or more bypass grafts demonstrated more significant preoperative comorbidity and disease severity. Patients undergoing 2 and >2 grafts in addition to AVR had increased mortality as compared to patients undergoing AVR and only 1 graft [odds ratio (OR) 1.17, 95% confidence interval (CI) [1.05-1.30], P = 0.005 and OR 1.15, 95% CI [1.02-1.30], P = 0.024 respectively]. A single arterial conduit was associated with a reduction in mortality (OR 0.75, 95% CI [0.68-0.82], P < 0.001) and postoperative dialysis (OR 0.87, 95% CI [0.78-0.96], P = 0.006), but this association was lost with >1 arterial conduit. One hundred and three surgeons responded to our survey, with only a small majority believing that the number of bypass grafts can influence short- or long-term postoperative outcomes in these patients, and an almost equal split in responders supporting the use of staged or hybrid interventions for patients with concomitant pathology. CONCLUSIONS: The number of grafts performed during combined AVR and coronary artery bypass grafting is associated with increased morbidity and mortality. The use of an arterial graft was also associated with reduced mortality. Future studies are needed to assess the effect of incomplete revascularization and measure long-term outcomes. Based on our data, current published evidence, and the collective expert opinion we gathered, we endorse future work to investigate the short and long-term efficacy and safety of hybrid intervention for patients with concomitant advanced coronary and aortic valve disease.
引用
- Fudulu DP, Layton GR, Nguyen B, et al. Trends and outcomes of concomitant aortic valve replacement and coronary artery bypass grafting in the UK and a survey of practices. Eur J Cardiothorac Surg. 2023. PMID: 37462523. doi:10.1093/ejcts/ezad259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。